3 Pathogenesis of NIDDM—a disease of deficient insulin secretion
- 1 May 1988
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Endocrinology and Metabolism
- Vol. 2 (2) , 327-342
- https://doi.org/10.1016/s0950-351x(88)80035-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETESThe Lancet, 1987
- Hyperinsulinemia in a Population at High Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1986
- Heterogeneity of insulin secretion in type II diabetesDiabetes/Metabolism Research and Reviews, 1986
- The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitusDiabetes, 1985
- Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapyDiabetes, 1982
- Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics.BMJ, 1981
- THE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETESClinical Endocrinology, 1981
- Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*Journal of Clinical Endocrinology & Metabolism, 1979
- Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetesDiabetes, 1979
- THE PLASMA INSULIN RESPONSE TO GLUCOSE INFUSION IN HEALTHY SUBJECTS AND IN DIABETES MELLITUSActa Endocrinologica, 1967